39562-22-6Relevant articles and documents
Preparation method of cilnidipine
-
Paragraph 0029; 0034; 0038; 0042, (2020/05/08)
The invention discloses a preparation method of high-purity cilnidipine. Methoxyethyl acetoacetate reacts with m-nitrobenzaldehyde to generate 2-(3-nitrobenzylidene) methoxyethyl acetoacetate, and the2-(3-nitrobenzylidene) methoxyethyl acetoacetate reacts with cinnamyl 3-aminocrotonate to generate cilnidipine. According to the method, the refining step of the 2-(3-nitrobenzylidene) methoxyethyl acetoacetate is added; the problem that impurities in the cilnidipine bulk drug are difficult to remove is solved, the subsequent refining process of the cilnidipine is simpler, and the purity of the finished product is high. The method has the advantages of simple synthesis process, complete reaction, high yield and low cost, and is very suitable for industrial production. .
Design and synthesis of 4-alkyl-2-amino(acetamino)-6-aryl-1,3-thiazine derivatives as influenza neuraminidase inhibitors
Li, Wan,Xia, Lin,Hu, Aixi,Liu, Ailin,Peng, Junmei,Tan, Weiqing
, p. 635 - 644 (2013/09/24)
With a convenient and economical method, two series of 1,3-thiazine derivatives 1 and 2 were synthesized, and their neuraminidase (NA) inhibitory activities were evaluated. The pharmacological results showed that most of the compounds have potent NA inhibitory activity. Especially, 1g exhibited the best activity against influenza virus A (H1N1) NA (IC50 = 29.06 μg/mL), and its crystal structure was determined by single-crystal X-ray diffraction. The preliminary biological assay indicated that 1,3-thiazine could be used as a core structure to design novel influenza NA inhibitors. Two series of novel 1,3-thiazine analogs were synthesized and their neuraminidase (NA) inhibitory activities were evaluated. Most of the compounds have potent NA inhibitory activity. Compound 1g exhibited the best activity against influenza virus A (H1N1) NA with an IC50 of 29.06 μg/mL, and its crystal structure was determined by single-crystal X-ray diffraction.
Novel 2-amino-1,4-dihydropyridine calcium antagonists. II. Synthesis and antihypertensive effects of 2-amino-1,4-dihydropyridine derivatives having N,N-dialkylaminoalkoxycarbonyl groups at 3- and/or 5-positions
Kobayashi,Inoue,Nishino,Fujihara,Oizumi,Kimura
, p. 797 - 817 (2007/10/02)
Novel 2-amino-1,4-dihydropyridine derivatives I, which contain N,N-dialkylaminoalkoxycarbonyl groups at the 3- and/or 5-position, were synthesized and their antihypertensive effects were evaluated in spontaneously hypertensive rats. Remarkably prolonged duration of antihypertensive action was observed when a tertiary amino group was introduced into either the 3- or 5-ester side-chain of the 1,4-dihydropyridine ring. In particular, the compounds containing cyclic amino moieties at the 3-position showed greater potency than those with acyclic amino moieties. Chemical modification studies indicated that the two ester side-chains of 1,4-dihydropyridine at the 3- and 5-position might function in a different manner in relation to the antihypertensive activities. 3-(1-Benzhydrylazetidin-3-yl) 5-isopropyl 2-amino-1,4-dihydro-6-methyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxyl ate, I-43 (CS-905), exhibited potent and long-lasting antihypertensive effects with gradual onset of action, and is a promising candidate as an antihypertensive drug.
